Dual antiplatelet treatment after stenting: is longer better?

被引：6
|
作者：
Sibbing, Dirk [1 ]
Massberg, Steffen
机构：
[1] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany
来源：
LANCET | 2014年 / 384卷 / 9954期
关键词：
DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; CONTROLLED-TRIAL; DOUBLE-BLIND; THERAPY; IMPLANTATION; DURATION; MULTICENTER; THROMBOSIS; RATIONALE;
D O I：
10.1016/S0140-6736(14)60768-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1553 / 1555
页数：3
相关论文
共 50 条
  • [1] Dual antiplatelet treatment after stenting
    Auer, Johann
    Berent, Robert
    LANCET, 2015, 385 (9965) : 325 - 326
  • [2] Duration of dual antiplatelet therapy after coronary stenting
    Briasoulis, Alexandros
    Palla, Mohan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 1064 - 1067
  • [3] Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome
    Varenhorst, Christoph
    Jensevik, Karin
    Jernberg, Tomas
    Sundstrom, Anders
    Hasvold, Pal
    Held, Claes
    Lagerqvist, Bo
    James, Stefan
    EUROPEAN HEART JOURNAL, 2014, 35 (15) : 969 - +
  • [4] Current developments in dual antiplatelet therapy after stenting
    Giacoppo, D.
    Baber, U.
    Mehran, R.
    MINERVA CARDIOANGIOLOGICA, 2014, 62 (03): : 261 - 276
  • [5] Duration of Dual Antiplatelet Therapy After Coronary Stenting
    Siasos, Gerasimos
    Mourouzis, Konstantinos
    Oikonomou, Evangelos
    Vavuranakis, Manolis
    Vogiatzi, Georgia
    Briasoulis, Alexandros
    Papageorgiou, Nikolaos
    Papaioannou, Theodore G.
    Zografos, Thodoris
    Papapanagiotou, Angeliki
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (29) : 4583 - 4595
  • [6] Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
    Cho, Min Soo
    Park, Duk-Woo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05) : 769 - 779
  • [7] Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
    Luo, Lin
    Wang, Shenglin
    Tang, Kai
    Yang, Xu
    Wu, Jianli
    Wang, Dan
    Xu, Liqiong
    Feng, Tao
    Li, Dejin
    Ran, Jiuju
    Li, Debo
    Zhang, Li
    Zhao, Dan
    MEDICINE, 2022, 101 (42) : E31158
  • [8] Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study
    Meredith, Ian T.
    Tanguay, Jean-Francois
    Kereiakes, Dean J.
    Cutlip, Donald E.
    Yeh, Robert W.
    Garratt, Kirk N.
    Lee, David P.
    Steg, P. Gabriel
    Weaver, W. Douglas
    Holmes, David R., Jr.
    Brindis, Ralph G.
    Trebacz, Jaroslaw
    Massaro, Joseph M.
    Hsieh, Wen-Hua
    Mauri, Laura
    CIRCULATION, 2016, 133 (18) : 1772 - +
  • [9] Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study
    Secemsky, Eric A.
    Yeh, Robert W.
    Kereiakes, Dean J.
    Cutlip, Donald E.
    Cohen, David J.
    Steg, P. Gabriel
    Cannon, Christopher P.
    Apruzzese, Patricia K.
    D'Agostino, Ralph B., Sr.
    Massaro, Joseph M.
    Mauri, Laura
    JAMA CARDIOLOGY, 2017, 2 (05) : 478 - 487
  • [10] Duration of Dual Antiplatelet Therapy After Coronary Stenting A Review of the Evidence
    Montalescot, Gilles
    Brieger, David
    Dalby, Anthony J.
    Park, Seung-Jung
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (07) : 832 - 847
12345